Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 12 relevant journals, 7 Conferences/workshops are presently dedicated exclusively to obesity and about 514 articles are being published on obesity.
Obesity is a condition in which abnormal or excessive fat accumulation in adipose tissue impairs health. Scientifically, According to the WHO (2006), a person is of normal weight if he or she has a BMI between 18.50 and 24.99. A person with a BMI of 25 or more is considered overweight, while anyone with a BMI of 30 or more is considered obese. Overweight and obesity are the fifth leading risk for global deaths. At least 2.8 million adults die each year as a result of being overweight or obese. In addition, 44% of the diabetes burden, 23% of the ischaemic heart disease burden and between 7% and 41% of certain cancer burdens are attributable to overweight and obesity.
Some WHO global estimates from 2008 follow:
In 2011, more than 40 million children under the age of five were overweight. Once considered a high-income country problem, overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban settings. More than 30 million overweight children are living in developing countries and 10 million in developed countries.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Globally, overweight and obesity are now the fifth leading risk for premature death. Almost 3 million adults die each year. It is estimated that the adult obesity rates in the UK - among the EU's worst - have more than tripled since 1980. Even in France - among the EU's best - obesity rates grew 3% in 1997 to 2003. According to country estimates for 2008, between 25% and 43% of both men and women in the WHO European Region were overweight and roughly 23% of women and 20% of men were obese. Based on the latest estimates in European Union countries, overweight affects 30-70% of the adult population while obesity affects 10-30% of adults. Projecting current trends in the increasing numbers of Europeans who are becoming obese to 2025, a staggering 30% of men and 34% of women will be obese unless something is done to reverse the trends. Eleven million EU children are already overweight and a further 3 million are obese, with 1.27 million overweight and 300,000 obese children joining the ranks each year, according to International Association for the Study of Obesity (IASO).
For the anti-obesity drugs market, growing rates of obesity worldwide are offering huge opportunities for drug manufacturing companies to develop and manufacture highly effective drugs. The landscape is vast, with competitors ranging from Arena Pharmaceuticals and Orexigen Therapeutics to big pharmaceutical companies, gearing up to make better, more effective anti-obesity drugs with fewer side effects.
The Global Anti-obesity Drugs market is divided into two segments:
The global anti-obesity drugs market is set to grow at a CAGR of 39.45% over the period 2014-2019. Whereas the anti-obesity drugs market in the US is expected to grow at a CAGR of more than 29% from 2015-2019. Worldwide weight loss/obesity management market is expected to reach $361 billion by 2017.
List of Associations/Organizations
This page will be updated regularly.
This page was last updated on January 10, 2026
